NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19

The trials will be conducted at more than 100 sites around the world and will involve patients in various clinical settings.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news